208 results
424B3
RNVA
Rennova Health, Inc.
26 Mar 24
Prospectus supplement
5:20pm
of Series B Warrants shall count toward the satisfaction of an Exercise Condition. Other than the Series B Warrants to acquire 101,350,000,000 shares
8-K
RNVA
Rennova Health, Inc.
26 Mar 24
Rennova Health, Inc., Announces the Expiration of Warrants to Purchare Over Four Hundred Billion Common Shares
5:15pm
, reclassifications, recapitalizations or other similar events. No cashless exercise of Series B Warrants shall count toward the satisfaction of an Exercise
424B3
RNVA
Rennova Health, Inc.
16 May 23
Prospectus supplement
4:16pm
, and the loan outstanding was reduced in satisfaction of the aggregate exercise price of $2.5 million. In August 2016, $0.3 million was repaid by the Company
8-K
EX-10.1
ge0ufidrbvv468 a1
1 Feb 22
Entry into a Material Definitive Agreement
8:30am
8-K
9s2kw0s bzomk1
1 Feb 22
Entry into a Material Definitive Agreement
8:30am
8-K
EX-3.28
m7d82 mel
8 Nov 21
Entry into a Material Definitive Agreement
9:00am
8-K
21ho34 j9dfs5ig
28 Oct 21
Entry into a Material Definitive Agreement
9:10am
8-K
EX-10.1
qlbr4
28 Oct 21
Entry into a Material Definitive Agreement
9:10am
8-K
ratam2
8 Sep 21
Entry into a Material Definitive Agreement
8:12am
8-K
EX-10.1
1wnfwbfgd
8 Sep 21
Entry into a Material Definitive Agreement
8:12am
8-K
EX-10.1
vbczxfz9gle8e6bx
2 Sep 21
Entry into a Material Definitive Agreement
5:29pm
8-K
55zi5wx8u2b
16 Jul 21
Entry into a Material Definitive Agreement
5:15pm